Georgetown University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Georgetown University sits in the top decile of US sponsors by registered trial count (#144 of 15,742 sponsors by registered trial count).
Georgetown University: 227 sponsored US clinical trials, 34 recruiting.
Georgetown University sponsors 227 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 130 completed. 27 of these trials are in Phase 3-4 (later-stage) and 98 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 5 trials.
Top-decile sponsor footprint
Georgetown University ranks in the top decile of sponsors by registered trial count (#144 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
130 of 174 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (74.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
227 total, page 5 of 5
Study on Effective Mydriasis in Premature Infants
NCT01054027
Vascular Sealant Study
NCT00618358
Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants
NCT00459238
Decreasing Rates of Illness in Kids (DRINK)
NCT00356382
Placebo Controlled Trial of Bosentan in Scleroderma Patients
NCT00377455
Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions
NCT00262899
Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery
NCT00457886
Chinese Women and Mammography Screening
NCT01261520
Telephone-Based Genetic Counseling or Standard Genetic Counseling in Women at Risk of Carrying the BRCA1 or BRCA2 Mutation
NCT00287898
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
NCT00377949
Urban Environmental Exposures and Childhood Cancer
NCT00505141
Prostate Cancer Screening: Fostering Informed Decisions
NCT00196807
Internet and Telephone Counseling for Smoking Cessation
NCT00282009
Cognitive Therapy to Improve Word Finding
NCT00494520
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
NCT00073073
Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet
NCT01324245
Treatment Decision Making in Early-Stage Prostate Cancer
NCT00196781
Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
NCT00088829
Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer
NCT00020748
Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast
NCT00898937
Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
NCT00004495
Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
NCT00003125
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer
NCT00003297
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
NCT00003035
VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin
NCT00004030
Low Dose Cyclosporin and Methotrexate Therapy in Diabetes
NCT00905073
Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects
NCT00091741
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 43 |
| Phase 2 | 55 |
| Phase 3 | 16 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the Georgetown University pipeline
34 recruiting of 227 indexed (15% open); 130 completed (57%).
Phase mix: 27 late (III/IV) vs 98 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Georgetown University: open-pipeline peers nationwide
Peers matched on 227 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Georgetown University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 227 trials (± recruiting share)
- University of Iowa · 228 trials · 12% recruiting
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
- Brown University · 231 trials · 15% recruiting
- National Eye Institute (NEI) · 221 trials · 8% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arizona State University · 15% recruiting · 187 trials
- 59th Medical Wing · 15% recruiting · 20 trials
- Alliance Foundation Trials · 15% recruiting · 20 trials
- Hoag Memorial Hospital Presbyterian · 15% recruiting · 20 trials
Related
What to do with this Georgetown University page
227 registered trials is a research-attention snapshot, not an endorsement of Georgetown University or any single study.
- 34 of Georgetown University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Georgetown University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Georgetown University pipeline card: 227 registered trials from official public datasets.Report a data error.